IPCA LABORATORIES - stock earnings
IPCALAB.NS Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 27, 2024 BeforeMarket | - / 5.6000000000 | - | - / 15.1 billion | - |
IPCALAB.NS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.8 billion INR | 20.5 billion INR |
| 2023Q3 | 1.5 billion INR | 20.3 billion INR |
| 2023Q2 | 1.6 billion INR | 15.9 billion INR |
| 2023Q1 | 765.2 million INR | 15.1 billion INR |
| 2022Q4 | 1.1 billion INR | 15.5 billion INR |
| 2022Q3 | 1.4 billion INR | 16.0 billion INR |
| 2022Q2 | 1.4 billion INR | 15.9 billion INR |
| 2022Q1 | 1.6 billion INR | 15.9 billion INR |
| 2021Q4 | 2.0 billion INR | 14.3 billion INR |
| 2021Q3 | 2.5 billion INR | 15.4 billion INR |
| 2021Q2 | 3.1 billion INR | 15.7 billion INR |
| 2021Q1 | 1.6 billion INR | 10.4 billion INR |
| 2020Q4 | 2.7 billion INR | 14.1 billion INR |
| 2020Q3 | 2.7 billion INR | 13.6 billion INR |
| 2020Q2 | 4.5 billion INR | 15.3 billion INR |
| 2020Q1 | 860.1 million INR | 9.8 billion INR |
| 2019Q4 | 2.0 billion INR | 12.1 billion INR |
| 2019Q3 | 1.9 billion INR | 12.8 billion INR |
| 2019Q2 | 1.3 billion INR | 10.8 billion INR |
| 2019Q1 | 985.5 million INR | 8.0 billion INR |
| 2018Q4 | 1.6 billion INR | 10.1 billion INR |
| 2018Q3 | 1.2 billion INR | 10.1 billion INR |
| 2018Q2 | 685.5 million INR | 8.8 billion INR |
| 2008Q1 | 279.0 million INR | 2.5 billion INR |
| 2007Q4 | 279.0 million INR | 2.7 billion INR |
| 2007Q3 | 454.2 million INR | 3.0 billion INR |
| 2007Q2 | 347.2 million INR | 2.5 billion INR |
IPCALAB.NS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 4.7 billion INR | 62.4 billion INR |
| 2022 | 8.8 billion INR | 57.7 billion INR |
| 2021 | 11.4 billion INR | 53.4 billion INR |
| 2020 | 6.1 billion INR | 45.6 billion INR |
| 2019 | 4.4 billion INR | 36.9 billion INR |
| 2018 | 2.4 billion INR | 32.1 billion INR |
| 2017 | 2.0 billion INR | 31.5 billion INR |
| 2016 | 967.3 million INR | 28.5 billion INR |
| 2015 | 2.6 billion INR | 31.2 billion INR |
| 2014 | 4.8 billion INR | 32.5 billion INR |
| 2013 | 3.2 billion INR | 27.7 billion INR |
| 2012 | 2.8 billion INR | 23.6 billion INR |
| 2011 | 2.6 billion INR | 18.8 billion INR |
| 2010 | 2.1 billion INR | 15.6 billion INR |
| 2009 | 1.0 billion INR | 12.8 billion INR |
| 2008 | 1.4 billion INR | 10.5 billion INR |
| 2007 | 1.3 billion INR | 9.4 billion INR |
| 2006 | 615.0 million INR | 7.6 billion INR |
| 2005 | 740.9 million INR | 6.8 billion INR |
IPCALAB.NS
Price: ₹1,301.70
Dividend Yield: 0.00%
Forward Dividend Yield: 0.15%
Payout Ratio: 8.97%
Dividend Per Share: 2.00 INR
Earnings Per Share: 22.19 INR
P/E Ratio: 59.43
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 329.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 7
DGR3: -29.49%
DGR5: 30.00%